Cargando…

Programmed Cell Death in Health and Disease

Detalles Bibliográficos
Autores principales:	Gibellini, Lara, Moro, Loredana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303776/ https://www.ncbi.nlm.nih.gov/pubmed/34359935 http://dx.doi.org/10.3390/cells10071765

Ejemplares similares

Programmed cell death lives
por: Griffioen, Arjan W., et al.
Publicado: (2022)

Cell Death in Human Health and Disease
por: Xu, Jianzhen, et al.
Publicado: (2014)

Mitochondria at the Crossroads of Physiology and Pathology
por: Moro, Loredana
Publicado: (2020)

The analgesic effect of programmed cell death protein-1
por: Park, Jong Yeon
Publicado: (2023)

Cell Self-Destruction (Programmed Cell Death), Immunonutrition and Metabolism
por: Yu, Ligen
Publicado: (2023)

Plant proteases and programmed cell death
por: Stael, Simon, et al.
Publicado: (2019)

Oxidative Stress and Inflammation Interaction in Ischemia Reperfusion Injury: Role of Programmed Cell Death
por: Yao, Weifeng, et al.
Publicado: (2019)

10 years of Cell Death & Disease
por: Piacentini, Mauro, et al.
Publicado: (2020)

Editorial of Special Issue “The Role of Vitamin D in Human Health and Diseases”
por: Silvagno, Francesca, et al.
Publicado: (2022)

Editorial of Special Issue “The Role of Vitamin D in Human Health and Diseases 2.0”
por: Silvagno, Francesca, et al.
Publicado: (2023)

Programmed Cell Death Protein 1–Positive CD8(+) T Cells in Multiple Sclerosis: Exhausted Fighters or Peacekeepers
por: Smolders, Joost, et al.
Publicado: (2022)

To Die or Not to Die: Cell Death in Biology and Disease
por: Krüger, Marcus, et al.
Publicado: (2022)

Editorial Note: Viral-mediated activation and inhibition of programmed cell death
Publicado: (2023)

Programmed death 1 blockade, an Achilles heel for MMR-deficient tumors?
por: Lin, Andy Yingjie, et al.
Publicado: (2015)

Cell Death and Neurodegenerative Diseases: Mechanisms and Cytoprotective Molecules
por: Vejux, Anne
Publicado: (2023)

Cell Death
por: Giampietri, Claudia, et al.
Publicado: (2014)

Exploring the mythical abscopal effect: Radiation and programmed cell death protein 1 (PD-1) blockade for hepatocellular carcinoma
por: Kim, Jun Won, et al.
Publicado: (2021)

Cell Programming for Cardiovascular Disease Modeling and Therapy
por: David, Robert
Publicado: (2023)

Cell Stress and Cell Death
por: Samali, Afshin, et al.
Publicado: (2010)

Cell death and senescence
por: Galluzzi, Lorenzo, et al.
Publicado: (2023)

Program Evaluation and Chronic Diseases: Methods, Approaches, and Implications for Public Health
por: Jack, Leonard, et al.
Publicado: (2005)

What is e-Health (2): The death of telemedicine?
por: Della Mea, Vincenzo
Publicado: (2001)

EcoHealth and the Black Death in the Year of the Rat
por: Zhang, Shu-yi, et al.
Publicado: (2008)

Diseases of Pregnancy and Fetal Programming: Cell and Molecular Mechanisms
por: Sobrevia, Luis, et al.
Publicado: (2014)

Inhibition of Lon protease by triterpenoids alters mitochondria and is associated to cell death in human cancer cells
por: Gibellini, Lara, et al.
Publicado: (2015)

Programmed death-ligand 1 expression discrepancy between primary tumor and metastatic lymph nodes in non-small cell lung cancer
por: Kian, Waleed, et al.
Publicado: (2020)

Cell death inhibition by KSHV
por: Murtadak, Vinay, et al.
Publicado: (2015)

Parietal Cell Death by Cytokines
por: Merchant, Juanita L.
Publicado: (2018)

Autophagy in Cell Survival and Death
por: Yang, Jinsung, et al.
Publicado: (2023)

Recent advances in cell death
por: Ha, Ki-Tae
Publicado: (2023)

Cell Death, Inflammation and Oxidative Stress in Neurodegenerative Diseases: Mechanisms and Cytoprotective Molecules
por: Vejux, Anne
Publicado: (2021)

Cell Death and Disease: a new journal for a central area of pathophysiology
por: Kroemer, G, et al.
Publicado: (2010)

Cell death-based treatment of various diseases: a fifty-year journey
por: Kaminskyy, Vitaliy O., et al.
Publicado: (2018)

Editorial: Liver diseases and programmed cell death
por: Cao, Peng, et al.
Publicado: (2023)

First-line pembrolizumab in programmed death ligand 1 positive non-small cell lung cancer
por: Travert, Camille, et al.
Publicado: (2019)

Lenvatinib/Pembrolizumab as second line treatment for advanced melanoma patients refractory to programmed death 1 (PD-1)/programmed death ligand-1 (PD-L1) inhibitors
por: Ferrucci, Pier Francesco
Publicado: (2023)

The CTSA program’s role in improving rural public health: Community-engaged disease prevention and health care innovation
por: Zhang, Xinzhi, et al.
Publicado: (2020)

A journal for global health programming
por: Shelton, James D, et al.
Publicado: (2013)

Health Physician and the Report of Deaths
Publicado: (1864)

Programmed cell death
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_0ibmu8rb0gv54fls63ipfa56nd